Clinical Trials Logo

Filter by:
NCT ID: NCT05804045 Active, not recruiting - Clinical trials for Tenosynovial Giant Cell Tumor

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Start date: April 27, 2023
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to assess the efficacy and safety of Pimicotinib (ABSK021) in patients with Tenosynovial Giant Cell Tumor (TGCT). The main questions it aims to answer are: - Whether the Pimicotinib(ABSK021) works well in patients with TGCT. - Whether the Pimicotinib(ABSK021) is safe in patients with TGCT. Participants will be asked to complete the study procedures: - Receive the administration of Pimicotinib(ABSK021) or placebo (a placebo is a look-alike substance that contains no active drug) about 24 weeks in study part 1. - Receive the administration of Pimicotinib(ABSK021) about 24 weeks in study part 2. - Receive the administration of Pimicotinib(ABSK021) till study end in study part 3. - Complete the study procedures speficied in the protocol, which is guided by researchers.

NCT ID: NCT05803720 Active, not recruiting - Stigma, Social Clinical Trials

HIV Provider Intervention to Address Intersectional Stigma and Medical Mistrust

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Intersectional stigma and medical mistrust are prevalent among Black and Latina/Latino Americans living with HIV and are key contributors to racial/ethnic health disparities; yet, there are no evidence-based provider-level interventions available for HIV care providers to address intersectional stigma and medical mistrust with patients. The investigators propose to develop an online provider intervention, with community stakeholders' input, that provides psychoeducation and skills-building around addressing intersectional stigma and medical mistrust with patients. The investigators will conduct a pilot randomized controlled trial with 60 HIV care physicians (30/condition) to test the acceptability and feasibility of the online intervention and to determine preliminary effects (against a no-intervention control group) on providers' use of skills and HIV care delivery outcomes at baseline, immediate post, and 6-month follow-up.

NCT ID: NCT05803304 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Web-based Physical Activity Intervention to Promote Physical Activity

Start date: October 16, 2023
Phase: N/A
Study type: Interventional

In this study insufficiently active adults with obesity will be assigned to either the Physical Activity for The Heart (PATH) intervention or an attention control group.

NCT ID: NCT05800145 Active, not recruiting - Hypertension Clinical Trials

Trial to Address Food Insecurity in Patients With Hypertension (SMART-FI)

SMART-FI
Start date: May 16, 2023
Phase: N/A
Study type: Interventional

In the US, 47% of adults have hypertension (HTN), and HTN accounts for more cardiovascular disease (CVD) deaths than any other CVD risk factor. Thus, the lack of an adaptive, stepped-care intervention to address FI in patients with HTN is a critical problem affecting a large, vulnerable population.

NCT ID: NCT05799066 Active, not recruiting - Clinical trials for Relative Afferent Pupil Defect (RAPD)

Measuring Relative Afferent Pupillary Defect

RAPD
Start date: May 4, 2023
Phase: N/A
Study type: Interventional

The goal of this prospective reliability study is to test the effectiveness of a commercially available, off-the-shelf virtual reality head-mounted display (VR HMD) and machine learning (ML) algorithms in detecting Relative Afferent Pupillary Defect (RAPD) in a group of subjects with known RAPD and another group with no known RAPD. The main questions it aims to answer are: - Does the use of the VR HMD and ML to replace the standard of care swinging flashlight test provide a more reliable and objective pupil measurement to detect RAPD? - Can RAPD be detected by the VR HMD and ML algorithms at an earlier stage than the standard of care swinging light test? Participants will be asked to undergo the standard of care swinging flashlight test, have their pupils manually measured, then have the test repeated using the VR HMD and ML. Researchers will compare the measurements taken manually, following the standard of care swinging light test and those recorded by the VR HMD and ML to help answer the above questions.

NCT ID: NCT05796648 Active, not recruiting - Obesity Clinical Trials

Preparing a Food Is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention - grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.

NCT ID: NCT05796518 Active, not recruiting - Endometrial Cancer Clinical Trials

Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Start date: September 7, 2023
Phase: N/A
Study type: Interventional

Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.

NCT ID: NCT05794997 Active, not recruiting - Hypertension Clinical Trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol

Start date: November 30, 2022
Phase:
Study type: Observational

This study aims to evaluate the comparative risk of dementia/Alzheimer's disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.

NCT ID: NCT05794763 Active, not recruiting - Eating Disorders Clinical Trials

The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention.

Start date: March 31, 2022
Phase: N/A
Study type: Interventional

This present study will compare the efficacy of in-person versus virtually-delivered Body Project groups. It will also evaluate whether this body acceptance class produces greater reductions in eating disorder risk factor symptoms (pursuit of the thin ideal, body dissatisfaction, dieting, dietary restraint, negative affect, eating disorder symptoms, and the future onset of eating disorders over a 3-month follow-up in this population. It will also evaluate the effectiveness of this body acceptance class's ability to impact social appearance anxiety, body compassion, and self-stigma surrounding attaining help.

NCT ID: NCT05794308 Active, not recruiting - Behavior, Health Clinical Trials

A Relational Artificial Intelligence (AI) Chatbot for App-Based Physical Activity Promotion

Start date: April 5, 2023
Phase: N/A
Study type: Interventional

This study aims to empirically test the theoretical mechanisms of relational perceptions in the context of building and testing a relational artificial intelligence (AI) chatbot for improving physical activity (PA) behaviors among a sedentary adult population in the U.S. The aim of the study is to build and experimentally test relational capacities of AI chatbot in inducing positive human-AI relationship and leading to higher PA behavior change intention. During the 7-day intervention, the relational chatbot will educate participants on physical activity using 5 types of relational messages during a PA intervention including 1) social dialogue, 2) empathy, 3) self-disclosure, 4) meta-relational communication, and 5) humor. On the other hand, the non-relational chatbot will only deliver PA intervention messages, without relational cues. Relational chatbot condition will be compared to the non-relational chatbot condition to assess its effectiveness. The objective of this study is to test the efficacy of the mobile app intervention leveraging chatbots in increasing participants' relationship perception and physical activity behavior change.